A novel model improves risk prediction for hypertrophic cardiomyopathy (HCM), according to results of a study.
The MIH model did not significantly reduce 30-day readmissions or improve overall health status compared to TOCC. Women and younger patients benefited more from the MIH model, showing reduced ...
Heart failure (HF) is estimated to affect over 60 million people globally and its prevalence is expected to rise as a consequence of aging populations. It results from an inability of the heart to ...
The powerful new AI tool can predict heart failure outcomes in specific patients, helping doctors improve care. UVA Health researchers have developed a powerful new risk assessment tool for predicting ...
Background Introduction of guideline-directed medical therapy (GDMT) has transformed the care of heart failure (HF) with ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...
One in three patients demonstrated discordant optimism, defined as estimating life expectancy >50% longer than model-estimated survival. Adjusted analyses associated overestimation with nearly doubled ...
Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...
Over the past 30 years, the number of people experiencing heart attacks has decreased by at least 50%, and the likelihood of death from a heart attack has declined by roughly 80%. Research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results